The Board unanimously approved the addition of the Partnership for Maternal, Newborn, and Child Health (PMNCH) to the non-voting Partners Board Delegation.
PMNCH joins Roll Back Malaria, the Stop TB Partnership, and UNITAID.
In a press release, the PMNCH stated:
The inclusion of the Partnership in this constituency is in recognition of the link between the 2017-2022 Global Fund Strategy which stresses the importance of women and girls; and the Partnership’s work to ensure women’s, children’s and adolescents’ wellbeing through the fight against AIDS, Malaria and Tuberculosis. Moreover, the 2017-2022 Strategy also places a strong emphasis on human rights, in addition to women and girls as the three diseases usually disproportionally impact these populations. This is also closely aligned with the Partnership’s work in support of the updated Global Strategy to reach such populations, everywhere. … Members of the Partnership are already engaged in providing guidance and technical assistance to the Global Fund recipients and play a central role in advocacy and engaging communities as well as a broad range of other efforts that have a direct relationship on the Global Fund grant implementation, including through central role of the Partnership with the Global Financing Facility.
PMNCH Executive Director Robin Gorna previously worked for the Department for International Development (DFID) and served on the U.K. Board Delegation. PMNCH Acting Deputy Executive Director Ann Lion previously worked for the U.S. Agency for International Development (USAID) and Office of the U.S. Global AIDS Coordinator (OGAC) and Abt Associates and served on the U.S. Government and Private Sector Board Delegations, respectively.